• Home /
  • Report Store /
  • Global Biological and Medical Imaging Reagents Market (2017-2022)

Global Biological and Medical Imaging Reagents Market (2017-2022)

Updated On: 07 January, 2019 | No of Pages: 90-100 | Format: PDF | SKU: 201858
  • Report Description
  • Table of Content
  • Request Sample
  • Customize Report
  • Speak to Analyst
  • Enquire before purchase

Rising cancer and cardiac mortality rates necessitate the use of advanced diagnostic procedures and techniques for faster and efficient detection of such conditions. As a result, the demand for biological and medical imaging reagents, in this context, has increased. The global biological and medical imaging reagents market is expected to reach approximately USD 11.22 Bn by 2022, expanding at a compound annual growth rate (CAGR) of 8% during the 2017-2022 period.

Global Bilogical and Medical Imaging Reagents (2018-2023)

Class segment insights:

The market is expected to be dominated by contrast reagents, owing to its extensive use in several diagnostic procedures like magnetic resonance imaging (MRI), positron emission tomography (PET) and computed tomography (CT), and x-rays. The radiopharmaceuticals segment occupies a market share of approximately 28% and has been witnessing consolidation in the last few years, which will strengthen radiopharmaceuticals’ pipelines and increase production scales. Though occupying a small share of the market, optical reagents are being used increasingly to develop advanced categories of patient-centric drugs.

Application segment insights:

The most widely used application area for imaging reagents are x-rays. The contrast agents in x-rays are used for the treatment of various types of disease conditions such as orthopedic and cardiovascular diseases, pneumonia, cancers/tumors, and dental diseases, among others. PET and CT occupies the second largest market share with approximately 29%. The MRI segment, holding a 15.1% share in 2017, is anticipated to have the highest growth in the next five years.

Routes of administration segment insights:

Among the various routes of administration, imaging reagents administered through injections held the largest market share (62%) in 2016 and is also expected to witness the fastest growth rate during the forecasted period.

End use segment insights:

The diagnosis sector generated the highest revenue in 2017 across various end use segments and is expected to maintain a similar revenue generation trend in the coming years.

Regional insights:

North America is the leading region, having accounted for a 45% market share in 2017. Concerted efforts by the Food and Drug Administration (FDA), National Cancer Institute (NCI), the pharmaceutical industry, and academia, have facilitated the growth of this market. Europe witnessed higher use of optical reagents, especially in utilizing the quantum dot technology. The region is poised for robust growth. Improving healthcare infrastructure and increasing health awareness in the developing markets of Asia-Pacific, Latin America, and the Middle East and Africa will result in higher adoption of medical imaging products, including reagents.

Companies covered:

• Bracco Imaging S.p.A

• Bayer Healthcare AG

• GE Healthcare

• Mallinckrodt Pharmaceuticals

• Lantheus Medical Imaging, Inc.

• Siemens Healthineers

• Thermo Fisher Scientific, Inc.

• Guerbet LLC

• Novartis

• J B Chemicals and Pharmaceuticals Ltd

 

Customizations available

With the given market data, Netscribes offers customizations according to specific needs. Write to us at support@researchonglobalmarkets.com, or connect with us here.

 

 

Estimated Delivery Time: 10

Chapter 1. Executive summary

 

1.1. Market scope and segmentation

1.2. Key questions answered

1.3. Executive summary

 

Chapter 2. Global biological and medical imaging reagents market – overview

 

2.1. Market overview - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), geography-wise market revenue (USD Bn), and market attractiveness analysis

2.2. Market drivers

2.3. Market trends

2.4. Market challenges

2.5. Value chain analysis

2.6. Porter's five forces analysis

2.7. Segmentation based on class (contrast reagents, radiopharmaceuticals, and optical reagents) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

2.8. Segmentation based on application (magnetic resonance imaging [MRI], positron emission tomography [PET] and computed tomography [CT], x-ray, and ultrasonography [USG]) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

2.9. Segmentation based on routes of administration (injection, oral, and enema) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

2.10. Segmentation based on end use (diagnosis, drug discovery, and research and development [R&D]) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

 

Chapter 3. North America biological and medical imaging reagents market

 

3.1. Regional market overview - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

3.2. Segmentation based on class (contrast reagents, radiopharmaceuticals, and optical reagents) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

3.3. Segmentation based on application (magnetic resonance imaging [MRI], positron emission tomography [PET] and computed tomography [CT], x-ray, and ultrasonography [USG]) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

3.4. Segmentation based on routes of administration (injection, oral, and enema) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

3.5. Segmentation based on end use (diagnosis, drug discovery, and research and development [R&D]) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

 

Chapter 4. Europe ADAS market

 

4.1. Regional market overview - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

4.2. Segmentation based on class (contrast reagents, radiopharmaceuticals, and optical reagents) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

4.3. Segmentation based on application (magnetic resonance imaging [MRI], positron emission tomography [PET] and computed tomography [CT], x-ray, and ultrasonography [USG]) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

3.4. Segmentation based on routes of administration (injection, oral, and enema) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

4.5. Segmentation based on end use (diagnosis, drug discovery, and research and development [R&D]) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

 

Chapter 5. Asia-Pacific biological and medical imaging reagents market

 

5.1. Regional market overview - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

5.2. Segmentation based on class (contrast reagents, radiopharmaceuticals, and optical reagents) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

5.3. Segmentation based on application (magnetic resonance imaging [MRI], positron emission tomography [PET] and computed tomography [CT], x-ray, and ultrasonography [USG]) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

5.4. Segmentation based on routes of administration (injection, oral, and enema) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

5.5. Segmentation based on end use (diagnosis, drug discovery, and research and development [R&D]) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

 

Chapter 6. Latin America biological and medical imaging reagents market

 

6.1. Regional market overview - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

6.2. Segmentation based on class (contrast reagents, radiopharmaceuticals, and optical reagents) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

6.3. Segmentation based on application (magnetic resonance imaging [MRI], positron emission tomography [PET] and computed tomography [CT], x-ray, and ultrasonography [USG]) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

6.4. Segmentation based on routes of administration (injection, oral, and enema) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

6.5. Segmentation based on end use (diagnosis, drug discovery, and research and development [R&D]) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

 

Chapter 7. The Middle East and Africa biological and medical imaging reagents market

 

7.1. Regional market overview - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

7.2. Segmentation based on class (contrast reagents, radiopharmaceuticals, and optical reagents) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

7.3. Segmentation based on application (magnetic resonance imaging [MRI], positron emission tomography [PET] and computed tomography [CT], x-ray, and ultrasonography [USG]) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

7.4. Segmentation based on routes of administration (injection, oral, and enema) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

7.5. Segmentation based on end use (diagnosis, drug discovery, and research and development [R&D]) - historical (2014-2016) and forecasted (2017-2022) market size (USD Bn), and key market observations

 

Chapter 8. Competitive landscape

 

8.1. Bracco Imaging S.p.A

8.1.a. Company snapshot

8.1.b. Product offerings

8.1.c. Growth strategies

8.1.d. Initiatives

8.1.e. Geographical presence

8.1.f. Key numbers

Note: Similar information areas will be covered for the remaining competitors

8.2. Bayer Healthcare AG

8.3. GE Healthcare

8.4. Mallinckrodt Pharmaceuticals

8.5. Lantheus Medical Imaging, Inc.

8.6. Siemens Healthineers

8.7. Thermo Fisher Scientific, Inc.

8.8. Guerbet LLC

8.9. Novartis

8.10. J B Chemicals and Pharmaceuticals Ltd

 

Chapter 9. Conclusion

9.1. Future outlook

 

Appendix

  • List of tables
  • Research methodology
  • Assumptions
  • About Netscribes Inc.

 

I agree to receiving communication from Research on Global Markets and Netscribes.

For customization of market research reports, fill out the form below, or write to us at support@researchonglobalmarkets.com.

I agree to receiving communication from Research on Global Markets and Netscribes.
I agree to receiving communication from Research on Global Markets and Netscribes.
I agree to receiving communication from Research on Global Markets and Netscribes.
$2,950.00
Loading...
Ready for Christmas?
Get a magic promo code on your email!